Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group-Reference-Cited by-同舟云学术

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group

Published:2016-11-11 Issue:51 Volume:7 Page:85306-85317
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Oudard Stéphane¹²,Elaidi Reza³,Brizard Mara³,Rest Céline Le³,Caillet Valérie²⁴,Deveaux Sophie²,Benoit Gérard²⁵,Corréas Jean-Michel²⁶,Benoudiba Farida²⁷,David Philippe²⁸,Gaudric Alain²⁴,Hammel Pascal²⁹,Joly Dominique²¹⁰,Timsit Marc Olivier²¹¹,Méjean Arnaud²¹¹,Richard Stéphane²¹²

Affiliation:

1. Department of Medical Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France

2. Réseau Expert National pour Cancers Rares de l’Adulte PREDIR AP-HP/INCa, Hôpital Bicêtre, Le Kremlin Bicêtre, France

3. Association pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, HEGP, Paris, France

4. Department of Ophthalmology, Hôpital Lariboisière, Paris, AP-HP, France

5. Department of Urology, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France

6. Department of Radiology, Hôpital Necker, AP-HP, Paris, France

7. Department of Neuroradiology, Hôpital Bicêtre, Le Kremlin-Bicêtre, AP-HP, France

8. Department of Neurosurgery, Hôpital Bicêtre, Le Kremlin-Bicêtre, AP-HP, France

9. Department of Digestive Oncology, Hôpital Beaujon, Clichy, AP-HP, France

10. Department of Nephrology, Hôpital Necker, Paris, AP-HP, France

11. Department of Urology, Hôpital Européen Georges Pompidou, Paris, AP-HP, France

12. Ecole Pratique des Hautes Etudes, Paris, France Laboratoire de Génétique Oncologique EPHE, INSERM, Villejuif, France and Faculté de Médecine Université Paris-Sud, Le Kremlin-Bicêtre, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Von-Hipple Lindau syndrome with family history: a case report and seventeen years follow-up study;Frontiers in Oncology;2024-03-26

2. Efficacy, Effectiveness, and Safety of Interventions for Von Hippel-Lindau Associated Renal Cell Carcinoma: A Systematic Literature Review;Kidney Cancer;2024-01-22

3. Systemic Therapy Options in VHL Disease;Von Hippel-Lindau Disease;2024

4. Targeting HIF-2 Alpha in Renal Cell Carcinoma;Current Treatment Options in Oncology;2023-07-05

5. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel–Lindau-Disease-Associated Tumors;Medical Sciences;2023-06-30